Tumor Size, Axillary Lymph Node Status and Steroid Receptor Expression in Breast Cancer: Prognostic Relevance 5 Years after Surgery
- 1 September 2002
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 75 (2) , 167-173
- https://doi.org/10.1023/a:1019601928290
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical Utility of Serial Serum c-erbB-2 Determinations in the Follow-up of Breast Cancer PatientsBreast Cancer Research and Treatment, 2002
- Prognostic and predictive factors in breast cancerCancer Treatment Reviews, 2001
- Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up studyThe Lancet, 1999
- Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast CancerJNCI Journal of the National Cancer Institute, 1998
- Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast CancerNew England Journal of Medicine, 1992
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 1989
- Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.Journal of Clinical Oncology, 1988
- Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancerBreast Cancer Research and Treatment, 1986
- Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic gradingCancer, 1984